Effect of Endogenous Neuropeptide Cycloprolylglycine on GABAA Receptors in Cerebellar Purkinje Cells
Voltage clamp and concentration-jump methods were employed to examine the effects of endogenous neuropeptide cycloprolylglycine on GABA-activated ionic currents in isolated cerebellar Purkinje cells. In the concentration range of 0.1-10.0 μM, short-term (600 msec) external application of cycloprolylglycine against the background of GABA-evoked current produced no effect on its amplitude. In contrast, application of 1 μM cycloprolylglycine increased current up to 177±15% control level. The development of potentiating effect and return to the control level of ionic current were slow, which was indicative of possible implication of second messenger systems in these processes. Functional augmentation of GABAA receptors under the action of cycloprolylglycine can underlie the established neuroprotective and anxiolytic effects of this endogenous dipeptide.
Key Wordscycloprolylglycine GABAA receptor cerebellum isolated neurons patch clamp
Unable to display preview. Download preview PDF.
- 1.Ashmarin IP, Koroleva SV, Myasoedov NF. Synactones – functionally conjugated complexes of endogenous regulators. Eksp. Klin. Farmakol. 2006;69(5):3-6. Russian.Google Scholar
- 3.Gudasheva TA, Vasilevich NI, Zolotov NN, Lezina VP, Rozenberg SG, Kravchenko EV, Ostrovskaya RU, Voronina TA, Rozantsev GG, Skoldinov AP. On the mechanism of nootropic action of topological analogues of piracetam based on proline. Khim.-Farm. Zh. 1991;25(6):12-15. Russian.Google Scholar
- 5.Kolyasnikova KN, Gudasheva TA, Nazarova GA, Antipov PI, Nikolaev SV, Antipova TA, Voronina TA, Seredenin SB. Similarity of Cycloprolylglycine to Piracetam in Antihypoxic and Neuroprotective Effects. Eksp. Klin. Farmakol. 2012;75(9):3-6. Russian.Google Scholar
- 6.Shuvaev AN, Salmin VV, Kuvacheva NV, Pozhilenkova EA, Salmina AB. Current trends in the development of the method of local potential fixation: new opportunities for neuropharmacology and neurobiology. Annaly. Klin. Eksp. Nevrol. 2015;9(4):54-58. Russian.Google Scholar
- 8.Ferro JN, de Aquino FL, de Brito RG, dos Santos PL, Quintans J de S, de Souza LC, de Araújo AF, Diaz BL, Lucca-Júnior W, Quintans-Júnior LJ, Barreto E. Cyclo-Gly-Pro, a cyclic dipeptide, attenuates nociceptive behaviour and inflammatory response in mice. Clin. Exp. Pharmacol. Physiol. 2015;42(12):1287-1295.CrossRefGoogle Scholar
- 11.Gudasheva TA, Boyko SS, Ostrovskaya RU, Voronina TA, Akparov VK, Trofimov SS, Rozantsev GG, Skoldinov AP, Zherdev VP, Seredenin SB. The major metabolite of dipeptide piracetam analogue GVS-111 in rat brain and its similarity to endogenous neuropeptide cyclo-L-prolylglycine. Eur. J. Drug Metab. Pharmacokinet. 1997;22(3):245-252.CrossRefGoogle Scholar
- 15.Porcher C, Hatchett C, Longbottom RE, McAinch K, Sihra TS, Moss SJ, Thomson AM, Jovanovic JN. Positive feedback regulation between gamma-aminobutyric acid type A (GABA(A)) receptor signaling and brain-derived neurotrophic factor (BDNF) release in developing neurons. J. Biol. Chem. 2011;286(24):21 667-21 677.CrossRefGoogle Scholar